ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B

NCT02313649 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 447

Last updated 2016-04-19

No results posted yet for this study

Summary

This study will evaluate how liver stiffness measurements made with ShearWave™ Elastography (SWE) correspond with a biopsy result (currently the gold standard). The population that will be evaluated are Chinese patients infected with the Hepatitis B virus.

Conditions

  • Liver Fibrosis

Sponsors & Collaborators

  • SuperSonic Imagine

    lead INDUSTRY

Principal Investigators

  • Ping Liang · People's Liberation Army General(301)Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313649 on ClinicalTrials.gov